Search - tctmd.com

Displaying 681 - 700 of 1038

Sort: Relevancy | Date

News Industry News

Elixir Medical Corporation to Announce 6-month Results of the DESolve Fully Bioresorbable Coronary Scaffold System Pivotal Trial at Late Breaking Trial Session of EuroPCR

May 01, 2013

News Daily News

High Platelet Reactivity Linked to More Adverse Events After Endovascular Procedures

Yael L. Maxwell

April 26, 2013

News Daily News

CABG Shows Mortality Advantage over PCI in ‘Real-world’ Multivessel Patients

April 26, 2013

News Industry News

ARCA biopharma and Medtronic to Collaborate on Atrial Fibrillation Clinical Trial for GencaroTM

April 22, 2013

News Daily News

Shock-Wave Preconditioning Boosts Cell Therapy for Chronic Heart Failure

L.A. McKeown

April 19, 2013

News Daily News

Zilver PTX 2-Year Results Published: Superior Safety, Efficacy vs. Angioplasty Sustained

April 12, 2013

News Industry News

CardioGuide System Enables Real-Time Navigation of Left Ventricular Leads During Medtronic CRT Implants

April 09, 2013

News Daily News

Silent Lesions Common after CAS, but Do Not Impact Hard Events

April 05, 2013

News Daily News

Un Estudio Resalta las Diferencias de Género en el Riesgo Hemorrágico tras una PCI

L.A. McKeown

March 25, 2013

News Daily News

Study Highlights Gender Differences in Bleeding Risk After PCI

L.A. McKeown

March 25, 2013

News Daily News

Sedation Plus Analgesia Improves Transradial PCI by Decreasing Spasm

Jason Kahn

March 25, 2013

News Daily News

BIOSOLVE-1 Shows Improvement in Paclitaxel-Eluting Bioabsorbable Stent

March 25, 2013

News Industry News

PLATINUM China Trial Demonstrates Positive Outcomes for The Boston Scientific PROMUS Element™ Stent

March 21, 2013

News Opinion Conversations in Cardiology

Conversations in Cardiology: Brief Question re: BMS-DES and DAPT

March 20, 2013

News Daily News

Remote Postconditioning Reduces AKI in NSTEMI Patients

March 15, 2013

News Conference News ACC 2013

ACC/i2 2013: Controversy, Late Breaking Trial News Dominate Busy Meeting

L.A. McKeown

March 14, 2013

News Conference News ACC 2013

SELECT-ACS: Novel Drug Limits Myocardial Damage After PCI for NSTEMI

Caitlin E. Cox

March 12, 2013

News Industry News

Cardiovascular Systems Presents Results from Pivotal Coronary Trial at ACC

March 11, 2013

News Industry News

New Data Reinforce Strong Long-Term Clinical Performance of Abbott's Absorb™ Bioresorbable Vascular Scaffold

March 11, 2013

News Daily News

Bleeding Score Helps Clinicians Target PCI Patients Best Suited for Bivalirudin

Caitlin E. Cox

March 09, 2013

Advertisement

Elixir Medical Corporation to Announce 6-month Results of the DESolve Fully Bioresorbable Coronary Scaffold System Pivotal Trial at Late Breaking Trial Session of EuroPCR

High Platelet Reactivity Linked to More Adverse Events After Endovascular Procedures

CABG Shows Mortality Advantage over PCI in ‘Real-world’ Multivessel Patients

ARCA biopharma and Medtronic to Collaborate on Atrial Fibrillation Clinical Trial for GencaroTM

Shock-Wave Preconditioning Boosts Cell Therapy for Chronic Heart Failure

Zilver PTX 2-Year Results Published: Superior Safety, Efficacy vs. Angioplasty Sustained

CardioGuide System Enables Real-Time Navigation of Left Ventricular Leads During Medtronic CRT Implants

Silent Lesions Common after CAS, but Do Not Impact Hard Events

Un Estudio Resalta las Diferencias de Género en el Riesgo Hemorrágico tras una PCI

Study Highlights Gender Differences in Bleeding Risk After PCI

Sedation Plus Analgesia Improves Transradial PCI by Decreasing Spasm

BIOSOLVE-1 Shows Improvement in Paclitaxel-Eluting Bioabsorbable Stent

PLATINUM China Trial Demonstrates Positive Outcomes for The Boston Scientific PROMUS Element™ Stent

Conversations in Cardiology: Brief Question re: BMS-DES and DAPT

Remote Postconditioning Reduces AKI in NSTEMI Patients

ACC/i2 2013: Controversy, Late Breaking Trial News Dominate Busy Meeting

SELECT-ACS: Novel Drug Limits Myocardial Damage After PCI for NSTEMI

Cardiovascular Systems Presents Results from Pivotal Coronary Trial at ACC

New Data Reinforce Strong Long-Term Clinical Performance of Abbott's Absorb™ Bioresorbable Vascular Scaffold

Bleeding Score Helps Clinicians Target PCI Patients Best Suited for Bivalirudin

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content